The NICOLA Recruitment Trial (NICOLA-RT)
Launched by QUEEN'S UNIVERSITY, BELFAST · Sep 9, 2013
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Recruiting, retaining and gathering complete data on participants in research projects, be they patients or health professionals, can be extremely difficult. These problems increase the risk that research will be abandoned before its true value is appreciated, or lead to delays in resolving uncertainty for decision makers, while further studies are done. Poor recruitment, retention and outcome collection frequently lead to many prospective studies being extended, increasing costs. Researchers need to use strategies that are themselves evidence-based. This study links with an existing longit...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must be aged 50 or over.
- • Participants must be living in an non-institutionalised environment.
- • Participants must be capable of providing informed consent.
- Exclusion Criteria:
- • Participants who are 49 or younger.
- • Participants who are institutionalised.
- • Participants who are not capable of providing informed consent.
About Queen's University, Belfast
Queen's University Belfast is a prestigious research institution located in Northern Ireland, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. The university actively engages in a diverse range of clinical trials, focusing on translational medicine and interdisciplinary collaboration to address pressing health challenges. With a strong emphasis on ethical standards and patient safety, Queen's University Belfast leverages its state-of-the-art facilities and a team of experienced researchers to contribute to the development of new therapies and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belfast, Northern Ireland, United Kingdom
Patients applied
Trial Officials
Mike Clarke, PhD
Principal Investigator
Queen's University, Belfast
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials